NDC 47426-302-06 - ZYNRELEF

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 47426-302
Requested NDC: 47426-302-06
Package NDCs from labels: 47426-302-06, 47426-302-04, 47426-302-02
Manufacturer: Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
Effective date: 2026-04-20
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
ZYNRELEF	Heron Therapeutics, Inc. \| Lifecore Biomedical \| Apitoria Pharma, Ltd. \| Cambrex Karlskoga AB \| Pharma Packaging Solutions	2026-04-20	HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
47426-302-02	2024-09-18	C162847	48780-1	1e7a6dab-1ec9-a2ce-e063-dadaa90aadf7	These highlights do not include all the information needed to use ZYNRELEF ® safely and effectively. See full prescribing information for ZYNRELEF. ZYNRELEF (bupivacaine and meloxicam) extended-release solution, for instillation use Initial U.S. Approval: 2021
47426-302-02	2024-07-30	C162847	48780-1	1e7a6dab-1ec9-a2ce-e063-dadaa90aadf7	These highlights do not include all the information needed to use ZYNRELEF ® safely and effectively. See full prescribing information for ZYNRELEF. ZYNRELEF (bupivacaine and meloxicam) extended-release solution, for instillation use Initial U.S. Approval: 2021

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
47426-302-02	ZYNRELEF	1 in 1 KIT	SOLUTION	1	16
47426-302-04	ZYNRELEF	1 in 1 CARTON	SOLUTION	1	16
47426-302-06	ZYNRELEF	10.5 mL in 1 VIAL, SINGLE-DOSE	SOLUTION	10.5	16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
47426-302	ZYNRELEF (BUPIVACAINE AND MELOXICAM) SOLUTION [HERON THERAPEUTICS, INC.]	13	Legacy NDC, 3 package rows	20241206_dab484a7-9353-43ba-9e74-7fab910c712b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 7 · 124 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
RIMSO-50	DIMETHYL SULFOXIDE	Mylan Institutional LLC	58b25d79-78f2-4953-b0c6-61658dc4ef0d	2021-03-17	Warnings, Adverse reactions	Exact identifier unii: YOW8V9698H
meloxicam	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	966ae650-ad7d-4de1-ab06-54992408fcfd	2021-03-11	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: VG2QF83CGL
Meloxicam	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	2a29daa9-74e5-4ed6-b5f1-ce04dc411b26	2020-07-20	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: VG2QF83CGL
Meloxicam	MELOXICAM	Exelan Pharmaceuticals Inc.	dfaac71c-dcc5-4b57-bf3b-616fccab96de	2018-09-19	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: VG2QF83CGL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.